192 related articles for article (PubMed ID: 32336424)
1. Blastic Plasmacytoid Dendritic Cell Neoplasm: The European Perspective.
Deconinck E
Hematol Oncol Clin North Am; 2020 Jun; 34(3):613-620. PubMed ID: 32336424
[TBL] [Abstract][Full Text] [Related]
2. Hematopoietic Cell Transplant for Blastic Plasmacytoid Dendritic Cell Neoplasm.
Kharfan-Dabaja MA; Cherry M
Hematol Oncol Clin North Am; 2020 Jun; 34(3):621-629. PubMed ID: 32336425
[TBL] [Abstract][Full Text] [Related]
3. Blastic Plasmacytoid Dendritic Cell Neoplasm: The Dermatologist's Perspective.
Hirner JP; O'Malley JT; LeBoeuf NR
Hematol Oncol Clin North Am; 2020 Jun; 34(3):501-509. PubMed ID: 32336415
[TBL] [Abstract][Full Text] [Related]
4. Blastic Plasmacytoid Dendritic Cell Neoplasm in Children.
Li Y; Sun V; Sun W; Pawlowska A
Hematol Oncol Clin North Am; 2020 Jun; 34(3):601-612. PubMed ID: 32336423
[TBL] [Abstract][Full Text] [Related]
5. Novel Therapies for Blastic Plasmacytoid Dendritic Cell Neoplasm.
Lane AA
Hematol Oncol Clin North Am; 2020 Jun; 34(3):589-600. PubMed ID: 32336422
[TBL] [Abstract][Full Text] [Related]
6. Tagraxofusp for Blastic Plasmacytoid Dendritic Cell Neoplasm.
Hammond D; Pemmaraju N
Hematol Oncol Clin North Am; 2020 Jun; 34(3):565-574. PubMed ID: 32336420
[TBL] [Abstract][Full Text] [Related]
7. Molecular Features of Blastic Plasmacytoid Dendritic Cell Neoplasm: DNA Mutations and Epigenetics.
Sapienza MR; Pileri S
Hematol Oncol Clin North Am; 2020 Jun; 34(3):511-521. PubMed ID: 32336416
[TBL] [Abstract][Full Text] [Related]
8. Blastic Plasmacytoid Dendritic Cell Neoplasm in 2020 and Beyond.
Lane AA
Hematol Oncol Clin North Am; 2020 Jun; 34(3):xiii-xiv. PubMed ID: 32336426
[No Abstract] [Full Text] [Related]
9. Immunotherapies Targeting CD123 for Blastic Plasmacytoid Dendritic Cell Neoplasm.
Xue T; Budde LE
Hematol Oncol Clin North Am; 2020 Jun; 34(3):575-587. PubMed ID: 32336421
[TBL] [Abstract][Full Text] [Related]
10. Blastic Plasmacytoid Dendritic Cell Neoplasm: Clinical Presentation and Diagnosis.
Deconinck E; Petrella T; Garnache Ottou F
Hematol Oncol Clin North Am; 2020 Jun; 34(3):491-500. PubMed ID: 32336414
[TBL] [Abstract][Full Text] [Related]
11. Blastic Plasmacytoid Dendritic Cell Neoplasm-Current Insights.
Venugopal S; Zhou S; El Jamal SM; Lane AA; Mascarenhas J
Clin Lymphoma Myeloma Leuk; 2019 Sep; 19(9):545-554. PubMed ID: 31281107
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy Options for Blastic Plasmacytoid Dendritic Cell Neoplasm.
Haddadin M; Taylor J
Hematol Oncol Clin North Am; 2020 Jun; 34(3):539-552. PubMed ID: 32336418
[TBL] [Abstract][Full Text] [Related]
13. Updates in Novel Therapies for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN).
Economides MP; Rizzieri D; Pemmaraju N
Curr Hematol Malig Rep; 2019 Dec; 14(6):515-522. PubMed ID: 31853773
[TBL] [Abstract][Full Text] [Related]
14. Role of tagraxofusp in treating blastic plasmacytoid dendritic cell neoplasm (BPDCN).
Alfayez M; Konopleva M; Pemmaraju N
Expert Opin Biol Ther; 2020 Feb; 20(2):115-123. PubMed ID: 31801379
[No Abstract] [Full Text] [Related]
15. Tagraxofusp as treatment for patients with blastic plasmacytoid dendritic cell neoplasm.
Lee SS; McCue D; Pemmaraju N
Expert Rev Anticancer Ther; 2020 Jul; 20(7):543-550. PubMed ID: 32460559
[TBL] [Abstract][Full Text] [Related]
16. Blastic plasmacytoid dendritic cell neoplasm (BPDCN): a rare entity.
Lim MS; Lemmert K; Enjeti A
BMJ Case Rep; 2016 Jan; 2016():. PubMed ID: 26791132
[TBL] [Abstract][Full Text] [Related]
17. Cytogenetics of Blastic Plasmacytoid Dendritic Cell Neoplasm: Chromosomal Rearrangements and DNA Copy-Number Alterations.
Sakamoto K; Takeuchi K
Hematol Oncol Clin North Am; 2020 Jun; 34(3):523-538. PubMed ID: 32336417
[TBL] [Abstract][Full Text] [Related]
18. Blastic Plasmacytoid Dendritic Cell Neoplasm: A Comprehensive Review of the Disease, Central Nervous System Presentations, and Treatment Strategies.
Mehra S; Taylor J
Cells; 2024 Jan; 13(3):. PubMed ID: 38334635
[TBL] [Abstract][Full Text] [Related]
19. Evaluating tagraxofusp for the treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN).
Wilson NR; Pemmaraju N
Expert Opin Pharmacother; 2022 Mar; 23(4):431-438. PubMed ID: 35060807
[TBL] [Abstract][Full Text] [Related]
20. Treatment of patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN): focus on the use of tagraxofusp and clinical considerations.
Pemmaraju N; Madanat YF; Rizzieri D; Fazal S; Rampal R; Mannis G; Wang ES; Foran J; Lane AA
Leuk Lymphoma; 2024 May; 65(5):548-559. PubMed ID: 38391126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
